# Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer

> **NCT03167775** · NA · UNKNOWN · sponsor: **BeiJing Yijiayi Medicine Techonoloy Co., Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Primary Liver Cancer

## Interventions

- **DRUG:** Elemene Injection/Elemene Oral Emulusion

## Key facts

- **NCT ID:** NCT03167775
- **Lead sponsor:** BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11-28
- **Primary completion:** 2019-05-27
- **Final completion:** 2019-11-27
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03167775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03167775, "Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03167775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*